Treatment of hematology patients with high-risk fever of unknown origin during neutropenia
In this MEDtalk, Nick De Jonge, a Hematologist working at the Amsterdam University Medical center, presents the main result of a landmark study published in Lancet Haematology. The study aims to improve antibiotic treatment for hematology patients presenting with fever.
